Skip to main content

Table 10 Global clinical assessment by the investigator in the PP set (no assessment in 103 patients)

From: Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections

Assessment

Investigator

Patient

Group

Nitroxoline (n = 148)

Controls (n = 158)

Nitroxoline (n = 148)

Controls (n = 158)

Very good

115 (77.7%)

138 (87.3%)

109 (73.6%)

123 (77.8%)

Good

19 (12.8%)

13 (8.2%)

26 (17.6%)

29 (18.4%)

Satisfactory

4 (2.7%)

5 (3.2%)

5 (3.4%)

4 (2.5%)

Moderate

1 (0.7%)

0 (0%)

3 (2.0%)

1 (0.6%)

Insufficient

9 (6.1%)

2 (1.3%)

5 (3.4%)

1 (0.6%)

p-value*

0.006

0.143

  1. *comparison of nitroxoline vs. controls (ordered probit regression with random center effect).